Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:
Metabasis Therapeutics Inc.   (ticker: MBRX)
Quote:Moleculin Biotech, Inc.(MBRX) MBRX Quotes on: Yahoo | Google
2.48
0.02 (0.8%)
Sep 22 - 4:00pm

5 day's Perf: 22.77%
1 Month Perf: 8.77%
3 Month Perf: 25.74%
YTD Perf: 8.77%
1 Year Perf: N/A%
Stock chart
Useful Quick Links for MBRX
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :          Hold          (Click Here For Details)
INSIDERS' Score: 50
0 100 50
BuySell
Latest 1 month: 0 0
Latest 6 Months: 24,000 200,000
52 Weeks: 24,000 200,000
Gurus' Indicator :          Hold          (Click Here For Details)
GURUS' Score: 50
0 100 50
Current Holdings: 0
Previous Holdings: 0
Change: 0
Institutions' Indicator :          Hold          (Click Here For Details)
INSTITUTIONS' Score: 50
0 100 50
Current Holdings: 0
Previous Holdings: 0
Change: 0
News And Links For The Group (Contribute a link)
[MBRX]   Moleculin Engages CRO to Begin Clinical Trials of WP1220 for the Treatment of Cutaneous T-Cell Lymphoma  (Marketwire)   13-Sep-17 07:30
[MBRX]   Moleculin to Collaborate on Combining its WP1122 Brain Cancer Drug Candidate with Roche's Drug Avastin  (Marketwire)   6-Sep-17 07:30
[MBRX]   Moleculin Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference  (Marketwire)   31-Aug-17 07:30
[MBRX]   Moleculin Announces Filing with FDA of IND for its Leukemia Drug Annamycin  (Marketwire)   29-Aug-17 07:30
[MBRX]   Moleculin Announces Meeting with European Medicines Agency  (Marketwire)   22-Aug-17 07:30
[MBRX]   Moleculin Acquires Active Drug Compound for the Treatment of Brain Cancer  (Marketwire)   16-Aug-17 07:30
[MBRX]   Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2017  (Marketwire)   14-Aug-17 07:30
[MBRX]   Moleculin Comments on Recent FDA Drug Approvals for Acute Myeloid Leukemia  (Marketwire)   9-Aug-17 07:30
[MBRX]   Moleculin Begins Clinical Testing Site Development Efforts in Poland; Selects Bioscience SA as Polish CRO  (Marketwire)   3-Aug-17 07:30
[MBRX]   Moleculin Strengthens Board of Directors with Appointment of John M. Climaco  (Marketwire)   27-Jul-17 07:30
[MBRX]   Moleculin's New Drug for the Treatment of Glioblastoma Nears Clinical Trials at MD Anderson Cancer Center  (Marketwire)   25-Jul-17 07:30
[MBRX]   Moleculin Signs Agreement with MD Anderson Cancer Center for Leukemia Drug, Annamycin  (Marketwire)   18-Jul-17 07:30
[MBRX]   Moleculin Regains Compliance with NASDAQ Listing Requirements  (Marketwire)   12-Jul-17 07:30
[MBRX]   Moleculin Appoints Lead European Principal Investigator for Planned Annamycin Clinical Trial  (Marketwire)   6-Jul-17 07:30
[MBRX]   Reminder: Moleculin Announces Conference Call to Discuss Recent New Discovery for Pancreatic Cancer and Business Update  (Marketwire)   29-Jun-17 07:30
[MBRX]   Moleculin Announces Conference Call to Discuss Recent New Discovery for Pancreatic Cancer and Business Update  (Marketwire)   27-Jun-17 07:30
[MBRX]   Moleculin Announces Scientific Support for Research Endeavor at Mayo Clinic  (Marketwire)   26-Jun-17 07:30
[MBRX]   Moleculin Announces Significant Discovery with Potential to Treat Pancreatic Cancer  (Marketwire)   21-Jun-17 07:30
[MBRX]   Moleculin Announces Intent to Expand Annamycin Planned Clinical Trial to Include Sites in Poland  (Marketwire)   15-Jun-17 07:00
[MBRX]   Moleculin Announces Preparation to File an IND with the FDA for WP1220 for Treatment of Cutaneous T-Cell Lymphoma  (Marketwire)   13-Jun-17 07:00
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*